Evidence map›Paper›PMID 34160717›Full record

ArticleJournal of artificial organs : the official journal of the Japanese Society for Artificial Organs2022

Rapid and sensitive mycoplasma detection system using image-based deep learning.

Hiroko Iseoka, Masao Sasai, Shigeru Miyagawa, Kazuhiro Takekita, Satoshi Date, Hirohito Ayame, Azusa Nishida, Sho Sanami, Takao Hayakawa, Yoshiki Sawa

Open access · hybridAbstract read
In one paragraph

Article in Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Hiroko Iseoka *Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Yamadaoka, 2-2, Suita-city, Osaka, 565-0871, Japan.
Masao Sasai *Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Yamadaoka, 2-2, Suita-city, Osaka, 565-0871, Japan.
Shigeru MiyagawaDepartment of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Yamadaoka, 2-2, Suita-city, Osaka, 565-0871, Japan.
Kazuhiro TakekitaDepartment of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Yamadaoka, 2-2, Suita-city, Osaka, 565-0871, Japan.
Satoshi DateDai Nippon Printing Co., Ltd., Shinjuku, Tokyo, Japan.
Hirohito AyameDai Nippon Printing Co., Ltd., Shinjuku, Tokyo, Japan.
Azusa NishidaDepartment of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Yamadaoka, 2-2, Suita-city, Osaka, 565-0871, Japan.
Sho SanamiDai Nippon Printing Co., Ltd., Shinjuku, Tokyo, Japan.
Takao HayakawaOsaka University Faculty of Medicine, Suita-city, Osaka, Japan.
Yoshiki SawaDepartment of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Yamadaoka, 2-2, Suita-city, Osaka, 565-0871, Japan. sawa-p@surg1.med.osaka-u.ac.jp.ORCID http://orcid.org/0000-0001-6132-9684
The University of Osaka · JPDai Nippon Printing (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A major concern in the clinical application of cell therapy is the manufacturing cost of cell products, which mainly depends on quality control. The mycoplasma test, an important biological test in cell therapy, takes several weeks to detect a microorganism and is extremely expensive. Furthermore, the manual detection of mycoplasma from images requires high-level expertise. We hypothesized that a mycoplasma identification program using a convolutional neural network could reduce the test time and improve sensitivity. To this end, we developed a program comprising three parts (mycoplasma detection, prediction, and cell counting) that allows users to evaluate the sample and verify infected/non-infected cells identified by the program. In experiments conducted, stained DNA images of positive and negative control using mycoplasma-infected and non-infected Vero cells, respectively, were used as training data, and the program results were compared with those of conventional methods, such as manual counting based on visual observation. The minimum detectable mycoplasma contaminations for manual counting and the proposed program were 10 and 5 CFU (colony-forming unit), respectively, and the test time for manual counting was 20 times that for the proposed program. These results suggest that the proposed system can realize a low-cost and streamlined manufacturing process for cellular products in cell-based research and clinical applications.

Indexed as

Deep LearningMycoplasmaAnimalsChlorocebus aethiopsVero CellsDeep learningMycoplasma contaminationTissue quality control

Identifiers

PMID34160717
PMCPMC8866286
OpenAlexW3177061275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.